Rafael Holdings, Inc. - 8-K Filing
Rafael Holdings released a July 8, 2026 investor presentation highlighting Trappsol® Cyclo's Phase 3 trial progress for Niemann-Pick Disease Type C1. (Items: 7.01 Regulation FD From July 8, 2026, the slide presentation (the “Presentation”) attached hereto as Exhibit 99, 9.01 Financial Statements and Exhibits)
Tickers: $RFL